AQR Capital Management
SGMO

AQR Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

AQR Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,535
Closed -$10.6K – 2867
2024
Q2 		$10.6K Sell
29,535
-843
-3% -$455 ﹤0.01% 2586
2024
Q1 		$20.4K Buy
+30,378
New +$22K ﹤0.01% 2391
2021
Q1 		– Sell
-15,957
Closed -$249K – 2258
2020
Q4 		$249K Buy
+15,957
New +$187K ﹤0.01% 2027
2019
Q1 		– Sell
-11,551
Closed -$133K – 2215
2018
Q4 		$133K Sell
11,551
-39,231
-77% -$487K ﹤0.01% 2126
2018
Q3 		$861K Sell
50,782
-4,958
-9% -$75.4K ﹤0.01% 1757
2018
Q2 		$792K Sell
55,740
-9,996
-15% -$166K ﹤0.01% 1809
2018
Q1 		$1.25M Buy
65,736
+9,364
+17% +$200K ﹤0.01% 1580
2017
Q4 		$925K Buy
56,372
+3,471
+7% +$51.6K ﹤0.01% 1708
2017
Q3 		$794K Buy
+52,901
New +$585K ﹤0.01% 1753
2014
Q4 		– Sell
-55,742
Closed -$601K – 2614
2014
Q3 		$601K Hold
55,742
– – ﹤0.01% 1871
2014
Q2 		$851K Hold
55,742
– – ﹤0.01% 1725
2014
Q1 		$1.01M Buy
55,742
+700
+1% +$13.5K ﹤0.01% 1697
2013
Q4 		$765K Sell
55,042
-11,258
-17% -$130K ﹤0.01% 1860
2013
Q3 		$695K Hold
66,300
– – ﹤0.01% 1830
2013
Q2 		$518K Buy
+66,300
New +$578K ﹤0.01% 1874

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

AQR Capital Management's SGMO Position: Q3 2024 in Review

AQR Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 29,535 shares — an estimated $10.6K sold.

AQR Capital Management first reported a position in SGMO in Q2 2013 and held it in 15 quarters. The position peaked at $1.25M in Q1 2018. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

  • AQR Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • AQR Capital Management sold 29,535 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $10.6K.
  • AQR Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 15 quarters.
  • AQR Capital Management's SANGAMO THERAPEUTICS INC position peaked at $1.25M in Q1 2018.
  • 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.